Novo Nordisk Renames Rybelsus Pill to Ozempic in US
1 maj, 15:03
1 maj, 15:03
09:03 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) on Friday said it renamed its oral semaglutide pill Rybelsus to Ozempic for easier recognition among diabetes patients and health workers.
Starting May 4, the relaunched and reformulated Ozempic tablets with 1.5-milligram, 4-milligram, and 9-milligram doses will be available in the US for adults with type 2 diabetes.
The Danish drugmaker said it will continue to market Rybelsus outside the US.
1 maj, 15:03
09:03 AM EDT, 05/01/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) on Friday said it renamed its oral semaglutide pill Rybelsus to Ozempic for easier recognition among diabetes patients and health workers.
Starting May 4, the relaunched and reformulated Ozempic tablets with 1.5-milligram, 4-milligram, and 9-milligram doses will be available in the US for adults with type 2 diabetes.
The Danish drugmaker said it will continue to market Rybelsus outside the US.
Aktieanalyser
USA:s ekonomi
Bostadsmarknad
Aktieanalyser
USA:s ekonomi
Bostadsmarknad
1 DAG %
Senast

OMX Stockholm 30
0,41%
(vid stängning)
Aker BP
Idag, 17:19
SEB höjer Aker
OMX Stockholm 30
1 DAG %
Senast
3 280,86